By Procos S.p.A.
To get in touch with Procos S.p.A., simply fill out the form below.
Subscribe to Supplier
Procos unveils new manufacturing facility plans at CPhI Japan
Procos is nearing the end of a development project to created the new 4000 m2 working space workshop, scheduled for completion in Autumn 2015. The new workshop is a central element in the company’s overall investment and growth strategy, focusing on its principle markets in North America, Europe and Japan
Expanded Capacity and Technologies
Procos and CBC Co. will share a stand at CPhI Japan at Booth 2B-37 in Tokyo’s Big Sight Exhibition Center.
The stand will feature a beautiful tridimensional ‘georama’ model of the new Procos facility at Cameri. The new workshop will provide a 40 per cent expansion in manufacturing capacity, up to 450m3, as well as new technology platforms to enable more innovative and creative solutions for demanding markets like oncology.
“Our appearance alongside CBC Co. at this premier event underlines our strong presence in the Japanese market,” said Kingo Yamashita, head of Procos’ Sales & Marketing Division.
“We have a team in Japan as caretakers of Procos activities inside of the CBC Group and manufacture of Japanese generics together with the custom synthesis activity are a key part of our strategy to drive continuous growth both in capacity and technology for high potency APIs,” said Mr. Yamashita.
“Our combined team at CPhI Tokyo will have a strong story to tell about our plans to bolster our new generic APIs pipeline for the Japanese market and the strategic importance of the new workshop,” he added.
Procos S.p.A. is an Italian Contract Research and Manufacturing Organization (CRO, CMO) that specializes in development, scale-up and production of APIs and cGMP advanced intermediates for the pharmaceutical industry.
Procos is an important member of the international CBC Group, headquartered in Japan. This network provides Procos with global reach, reinforced with subsidiary sales offices in the USA, Slovakia, Germany and India.
Over 70 years, Procos has built up a comprehensive range of technologies and capabilities to provide high quality products and services that have been widely accepted in worldwide pharmaceutical markets. It continuously develops and adds unique generic APIs and key intermediates to its product portfolio.
Procos’ two core business sectors are the development and supply of APIs and GMP advanced intermediates along with contract manufacturing services.
Procos manufactures more than 30 products, mostly under uniquely designed synthetic methods and under strict regulatory compliance management. In contract manufacturing, Procos provides related services for the pharmaceutical industry acting as a CRO/CMO for custom synthesis on exclusive base, supporting customer from early clinical stage up to full -scale commercial production. Development services include IP analysis expertise and effective patent challenge skills.
Innovation is a driving force of Procos activity. The company’s products are based on patented technologies and cost-effective processes. Procos chemistry expertise is focused on the most complex organic reactions, including organo-metallic catalysis, multi-catalytic hydrogenation, Enantioselective and hazardous chemistry.
About CPhI Japan 2015
CPhI Japan is one of the region’s premier pharma business and sourcing events, offering delegates opportunities to arrange face-to-face meetings with potential international partners and collaborators, as well as gain insights on latest industry trends.
Staged by global B2B events organizer and publisher, UBM Live, CPhI 2015 is being held April 22-24 at Tokyo’s Big Sight Exhibition Centre, alongside four other zoned exhibitions; P-MEC (including LabWorld) for machinery and equipment, ICSE for outsourcing solutions, BioPh for bio-technology and InnoPack for Drug Packaging and Delivery Technology.
It is expected to be the biggest CPhI Japan event to date, attracting close to 19,000 visitors, compared with 17,275 for the 2014 event. The event also attracts more than 400 exhibiting companies, representing 28 countries. The 2015 expo will feature national pavilions for Japan, China, South Korea, UK, India and Italy.
More information at: http://www.cphi.com/japan/home
Kingo Yamashita, Sales & Marketing Director, Procos SpA
Tel: +39 0321 642211
Click on Procos unveils new R&D facility plans at CPhI Japan for other information.
Click on Procos to contact the company directly.